The novel omega‐6 fatty acid docosapentaenoic acid positively modulates brain innate immune response for resolving neuroinflammation at early and late stages of humanized APOE‐based Alzheimer’s disease models: Nonhuman/Target identification and validation studies: Inflammation and innate immunity